Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Chromatography|May 10, 1985
Determination of antiepileptic drugsJ T Burke, J P Thénot
Journal of Chromatography|October 9, 1987
Correlation between reversed-phase high-performance liquid chromatography and plasma protein bindingJ Ganansia, G Bianchetti, J P Thénot
Journal of Pharmacokinetics and Pharmacodynamics|July 27, 2001
Population pharmacokinetic analysis and optimization of the experimental design for mizolastine solution in childrenF Mentré, C Dubruc, J P Thénot
Journal of Immunoassay|February 1, 1995
A noncompetitive enzyme immunoassay for rat prolactinV Tavernier, J P Thénot, M Parrod, et al.
Journal of Pharmacokinetics and Biopharmaceutics|October 31, 1998
Population pharmacokinetic analysis of mizolastine and validation from sparse data on patients using the nonparametric maximum likelihood methodF Mesnil, F Mentré, C Dubruc, et al.
Developmental Pharmacology and Therapeutics|January 1, 1989
Pharmacokinetics of antihypertensive drugs in the neonatal periodP L Morselli, M J Boutroy, G Bianchetti, et al.
Fundamental & Clinical Pharmacology|January 1, 1995
Pharmacokinetic and bioavailability of diltiazem sustained-release: influence of food and time of administrationG Bianchetti, H Bagheri, G Houin, et al.
Epilepsia|January 1, 1987
Pharmacokinetic interactions of progabide with other antiepileptic drugsG Bianchetti, P Padovani, J P Thénot, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1995
Oxidative metabolism of zolpidem by human liver cytochrome P450SL Pichard, G Gillet, C Bonfils, et al.
Pageof 2